New costly treatments for hepatitis C and cancer added to WHO essential drug list
The World Health Organization has added new costly treatments for hepatitis C, cancer and multi-drug resistant tuberculosis to its updated Model List of Essential Medicines, opening the way for potentially improved access at affordable prices by patients worldwide. …